NUTRA PHARMA CORP. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
NUTRA PHARMA CORP. (NPHC) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $610.48 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-21.
Discontinued › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2022-11-21
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2022-09-30 was $176.57K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2022-06-30 was $783.62K.
- NUTRA PHARMA CORP. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2022-03-31 was -$349.70K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | $176.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $960.18K derived: sum of 2 quarters · filed 2022-11-21 | $610.48K 10-Q · filed 2022-11-21 | ||
| 2022-06-30 | $783.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $433.92K 10-Q · filed 2022-08-22 | |||
| 2022-03-31 | -$349.70K 10-Q · filed 2022-05-20 | ||||
| 2021-12-31 | $69.84K 10-Q · filed 2022-11-21 | -$69.84K 10-Q · filed 2022-05-20 |